Literature DB >> 17459060

RNA interference-mediated signal transducers and activators of transcription 3 gene silencing inhibits invasion and metastasis of human pancreatic cancer cells.

Zhengjun Qiu1, Chen Huang, Jing Sun, Wei Qiu, Jufeng Zhang, Huiming Li, Tao Jiang, Kejian Huang, Jun Cao.   

Abstract

Signal transducers and activators of transcription-3 (STAT3), a central cytoplasmic transcription factor, is frequently overexpressed and constitutively activated by tyrosine during malignant transformation. The overexpression and phosphorylation of STAT3 in pancreatic cancer has been described only recently, but the roles and mechanism still remain unclear. In this study, we elucidate the significance of the STAT3 signaling pathway in metastatic potentials of pancreatic cancer. We stably silence the expression of the STAT3 and p-STAT3 by using RNA interference (RNAi) in the pancreatic cancer cell line SW1990, and then reduce its invasion capacity in vitro and metastasis capacity in vivo compared to parental cells or cells tansfected with a control vector. Furthermore, silencing SW1990 cells with the STAT3 gene by RNAi also led to a decrease of matrix metalloproteinases-2 (MMP-2) and vascular endothelial growth factor (VEGF) at the mRNA and protein level. Collectively, these studies suggest that activation of the STAT3 signaling pathway plays an important role in the progression of pancreatic cancer, and that silence of the STAT3 gene with RNAi may be a useful anti-invasive therapeutic option in pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17459060     DOI: 10.1111/j.1349-7006.2007.00485.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  26 in total

1.  STAT3 inhibition reduces toxicity of oncolytic VSV and provides a potentially synergistic combination therapy for hepatocellular carcinoma.

Authors:  S Marozin; J Altomonte; K A Muñoz-Álvarez; A Rizzani; E N De Toni; W E Thasler; R M Schmid; O Ebert
Journal:  Cancer Gene Ther       Date:  2015-05-01       Impact factor: 5.987

2.  Humanized Lewis-Y specific antibody based delivery of STAT3 siRNA.

Authors:  Yuelong Ma; Claudia M Kowolik; Piotr M Swiderski; Marcin Kortylewski; Hua Yu; David A Horne; Richard Jove; Otavia L Caballero; Andrew J G Simpson; Fook-Thean Lee; Vinochani Pillay; Andrew M Scott
Journal:  ACS Chem Biol       Date:  2011-07-26       Impact factor: 5.100

Review 3.  Crosstalk of Sp1 and Stat3 signaling in pancreatic cancer pathogenesis.

Authors:  Chen Huang; Keping Xie
Journal:  Cytokine Growth Factor Rev       Date:  2012-02-16       Impact factor: 7.638

4.  Downregulation of STAT3 signaling induces apoptosis but also promotes anti-apoptotic gene expression in human pancreatic cancer cell lines.

Authors:  Wolfgang Glienke; Eva Hausmann; Lothar Bergmann
Journal:  Tumour Biol       Date:  2010-12-21

5.  Down-regulation of STAT3 expression by vector-based small interfering RNA inhibits pancreatic cancer growth.

Authors:  Chen Huang; Guang Yang; Tao Jiang; Jun Cao; Ke-Jian Huang; Zheng-Jun Qiu
Journal:  World J Gastroenterol       Date:  2011-07-07       Impact factor: 5.742

6.  Effects of IL-6 and AG490 on regulation of Stat3 signaling pathway and invasion of human pancreatic cancer cells in vitro.

Authors:  Chen Huang; Guang Yang; Tao Jiang; Kejian Huang; Jun Cao; Zhengjun Qiu
Journal:  J Exp Clin Cancer Res       Date:  2010-05-19

7.  Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation.

Authors:  S E Wheeler; S Suzuki; S M Thomas; M Sen; R J Leeman-Neill; S I Chiosea; C-T Kuan; D D Bigner; W E Gooding; S Y Lai; J R Grandis
Journal:  Oncogene       Date:  2010-07-12       Impact factor: 9.867

8.  Microarray analysis of somatostatin receptor 5-regulated gene expression profiles in murine pancreas.

Authors:  Sanjeet G Patel; Guisheng Zhou; Shi-He Liu; Min Li; Jae-Wook Jeong; Francesco J DeMayo; Marie-Claude Gingras; Richard A Gibbs; William E Fisher; F Charles Brunicardi
Journal:  World J Surg       Date:  2009-04       Impact factor: 3.352

9.  Blockage of the STAT3 signaling pathway with a decoy oligonucleotide suppresses growth of human malignant glioma cells.

Authors:  Jinhai Gu; Gang Li; Tao Sun; Yuhang Su; Xulong Zhang; Jie Shen; Zhigang Tian; Jian Zhang
Journal:  J Neurooncol       Date:  2008-04-16       Impact factor: 4.130

10.  Inhibitory effect of cucurbitacin E on pancreatic cancer cells growth via STAT3 signaling.

Authors:  Chunyan Sun; Meixia Zhang; Xiaolei Shan; Xueying Zhou; Jiao Yang; Yanli Wang; Jesse Li-Ling; Yihui Deng
Journal:  J Cancer Res Clin Oncol       Date:  2009-10-09       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.